Reach the investors backing rounds like this
Backed by Ada Ventures, Delphinus Venture Capital +2 more · verified emails and LinkedIn on Datapile

Alcolase raises €1.5M to tackle alcohol intolerance with enzyme technology - Tech.eu
Alcolase is developing an enzyme-based technology designed to break down alcohol in the stomach before it is absorbed into the bloodstream.
Alcolase raises €1.5M to tackle alcohol intolerance with enzyme technology Tech.eu

| Aug 26, 2026 | os.energy | $1.1M | Pre-seed | Denmark |
| Aug 25, 2026 | Repodo | $8.5M | — | Denmark |
| Aug 11, 2026 | Copenhagen repeat | $3.2M | — | Denmark |
| Jul 13, 2026 | Visibuilt | $3.5M | — | Denmark |
You just read who funded Alcolase. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 5 investor contact unlocks a month, no card required.